Activity of plasminogen activator inhibitor-1 in blood of patients with metabolic syndrome depending on a stage of diabetic retinopathy
Background. The main cause for the development of proliferative diabetic retinopathy (DRP) is the absence of capillary perfusion, resulting in the initiation of retinal neovascularization. In ischemia reperfusion injury of the retina, the plasminogen activator inhibitor 1 (PAI-1), inflammatory media...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ukrainian Society of Ophthalmologists
2018-06-01
|
| Series: | Journal of Ophthalmology |
| Subjects: | |
| Online Access: | https://www.ozhurnal.com/en/archive/2018/3/8-fulltext |